Ellis WJ - Search Results

1

Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator.

Ankerst DP, Xia J, Thompson IM Jr, Hoefler J, Newcomb LF, Brooks JD, Carroll PR, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW. Ankerst DP, et al. Among authors: ellis wj. Eur Urol. 2015 Dec;68(6):1083-8. doi: 10.1016/j.eururo.2015.03.023. Epub 2015 Mar 25. Eur Urol. 2015. PMID: 25819722 Free PMC article. Clinical Trial.

2

Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.

Ellis WJ, Chetner MP, Preston SD, Brawer MK. Ellis WJ, et al. J Urol. 1994 Nov;152(5 Pt 1):1520-5. doi: 10.1016/s0022-5347(17)32460-6. J Urol. 1994. PMID: 7523710 Clinical Trial.

3

The significance of isoechoic prostatic carcinoma.

Ellis WJ, Brawer MK. Ellis WJ, et al. J Urol. 1994 Dec;152(6 Pt 2):2304-7. doi: 10.1016/s0022-5347(17)31663-4. J Urol. 1994. PMID: 7526001 Clinical Trial.

4

Repeat prostate needle biopsy: who needs it?

Ellis WJ, Brawer MK. Ellis WJ, et al. J Urol. 1995 May;153(5):1496-8. J Urol. 1995. PMID: 7536254

5

The inability of prostate specific antigen index to enhance the predictive the value of prostate specific antigen in the diagnosis of prostatic carcinoma.

Brawer MK, Aramburu EA, Chen GL, Preston SD, Ellis WJ. Brawer MK, et al. Among authors: ellis wj. J Urol. 1993 Aug;150(2 Pt 1):369-73. doi: 10.1016/s0022-5347(17)35485-x. J Urol. 1993. PMID: 7686982

6

Prostate cancer.

Ellis WJ, Lange PH. Ellis WJ, et al. Endocrinol Metab Clin North Am. 1994 Dec;23(4):809-24. Endocrinol Metab Clin North Am. 1994. PMID: 7705321 Review.

7

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study.

Higano CS, Ellis W, Russell K, Lange PH. Higano CS, et al. Urology. 1996 Nov;48(5):800-4. doi: 10.1016/S0090-4295(96)00381-0. Urology. 1996. PMID: 8911533 Clinical Trial.

8

Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.

Corey E, Arfman EW, Oswin MM, Melchior SW, Tindall DJ, Young CY, Ellis WJ, Vessella RL. Corey E, et al. Among authors: ellis wj. Urology. 1997 Aug;50(2):184-8. doi: 10.1016/S0090-4295(97)00262-8. Urology. 1997. PMID: 9255285

9

Improved detection of recurrent bladder cancer using the Bard BTA stat Test.

Sarosdy MF, Hudson MA, Ellis WJ, Soloway MS, deVere White R, Sheinfeld J, Jarowenko MV, Schellhammer PF, Schervish EW, Patel JV, Chodak GW, Lamm DL, Johnson RD, Henderson M, Adams G, Blumenstein BA, Thoelke KR, Pfalzgraf RD, Murchison HA, Brunelle SL. Sarosdy MF, et al. Among authors: ellis wj. Urology. 1997 Sep;50(3):349-53. doi: 10.1016/s0090-4295(97)00292-6. Urology. 1997. PMID: 9301696 Clinical Trial.

10

Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.

Ellis WJ, Vessella RL, Noteboom JL, Lange PH, Wolfert RL, Rittenhouse HG. Ellis WJ, et al. Urology. 1997 Oct;50(4):573-9. doi: 10.1016/S0090-4295(97)00251-3. Urology. 1997. PMID: 9338734 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters